Close Menu

In the Pipeline's Derek Lowe talks about the occasional "perverse incentives" in oncology drug development. Lowe references an article from 2007 in the Journal of Clinical Oncology written by an investor, Tony Fiorino, who talks about the motives behind oncology research at large pharmaceutical companies versus small biotech start-ups.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.